US2021393934A1PendingUtilityA1
MEDICAL DEVICES FOR DELIVERY OF siRNA
Est. expiryApr 28, 2030(~3.8 yrs left)· nominal 20-yr term from priority
Inventors:Russell F. Ross
A61M 2037/0023A61M 2037/0061Y10T29/49826A61M 5/158C12N 2310/14A61M 2037/0053A61P 35/00C12N 15/113A61M 37/0015C12N 15/89A61M 37/00A61M 2037/0038A61K 48/00A61P 31/00
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are medical devices that incorporate siRNA. In addition to one or more siRNA constructs, devices include nanostructures fabricated on a surface to form a nanotopography. A random or non-random pattern of structures may be fabricated such as a complex pattern including structures of differing sizes and/or shapes. Microneedles may be incorporated on devices. The pattern including nanostructures may be formed on the surface of the microneedles.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for delivering an siRNA construct across a dermal barrier, the method comprising:
penetrating the stratum corneum with a microneedle having a surface on which a plurality of nanostructures and a plurality of microstructures are arranged in a pattern that comprises a fractal and/or fractal-like geometry, wherein the nanostructures and microstructures project outward from the surface of the microneedle, and wherein the microneedle further contains a channel; transporting an siRNA construct from a reservoir through the channel of the microneedle and across the stratum corneum.
2 . The method of claim 1 , wherein the siRNA construct is transported across the stratum corneum at a steady concentration over a period of time.
3 . The method of claim 1 , wherein the siRNA construct includes a duplexed region of between about 20 and about 30 pairs.
4 . The method of claim 1 , wherein at least one strand of the siRNA construct includes a 3′ overhang of two or three nucleotides.
5 . The method of claim 1 , wherein the siRNA construct comprises additional nucleotides or nucleotide analogues.
6 . The method of claim 1 , wherein the siRNA construct includes insertions, deletions, or single point mutations compared to a portion of a targeted gene.
7 . The method of claim 1 , wherein the siRNA construct is a single strand siRNA.
8 . The method of claim 1 , wherein the siRNA comprises a ligand tethered to the siRNA.
9 . The method of claim 8 , wherein the ligand is selected from the group consisting of a therapeutic modifier, a diagnostic compound, a reporter group, a crosslinking agent, a nucleobase, a lipophilic molecule, a protein, or combinations thereof.
10 . The method of claim 1 , wherein the siRNA agent is incorporated into a delivery vehicle.
11 . The method of claim 10 , wherein the delivery vehicle is a liposome.
12 . The method of claim 1 , wherein the siRNA construct comprises a vector.
13 . The method of claim 12 , wherein the vector is a viral vector.
14 . A method of forming a device for delivery of an siRNA construct across a dermal barrier, the method comprising:
fabricating an array of microneedles; fabricating a pattern of nanostructures on a surface of at least one of the microneedles, wherein the pattern comprises a fractal and/or fractal-like geometry; and associating an siRNA construct with the microneedles such that the siRNA construct is in fluid communication with the microneedles.
15 . The method of claim 14 , further comprising retaining the siRNA construct within a reservoir that is in fluid communication with the array of microneedles.
16 . The method of claim 15 , wherein the reservoir is attached to a substrate upon which the array of microneedles are located.
17 . The method of claim 15 , wherein the reservoir is removably connectable to the array of microneedles.
18 . The method of claim 14 , wherein the pattern comprises a fractal dimension of greater than about 1.
19 . The method of claim 18 , wherein the fractal dimension is between about 1.5 and 2.5.
20 . The method of claim 14 , wherein the method further comprises fabricating a pattern of microstructures on the surface of at least one of the microneedles.Join the waitlist — get patent alerts
Track US2021393934A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.